Fabio
3.6 KiB
3.6 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE PRESCRIPTION MONITORING PROGRAM. | Far too many Delawareans have been personally affected by addiction and substance use disorder and have experienced the tragedy of watching loved ones suffer from this chronic disease. Nearly 2,000 individuals in Delaware suffered a non-fatal overdose in 2017, but data suggest that many of these individuals continued to be prescribed opioid pain medications or did not receive substance use disorder treatment. | us/states/de | Delaware General Assembly | 149 | SB 206 | Delaware SB 206 (149) |
|
enacted |
|
1 | 7 | 2 | 2018-05-08 | 2018-09-10 | openstates | ocd-bill/ae21e5c5-aaa4-466e-9ae0-817eb260cf17 | https://legis.delaware.gov/BillDetail?LegislationId=26661 | 770fbc38bf0eb2fa2f9618addd1b3db4b3b4cc284ca68c662e1f6edf1d11ed31 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware SB 206 (149) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE PRESCRIPTION MONITORING PROGRAM.
Far too many Delawareans have been personally affected by addiction and substance use disorder and have experienced the tragedy of watching loved ones suffer from this chronic disease. Nearly 2,000 individuals in Delaware suffered a non-fatal overdose in 2017, but data suggest that many of these individuals continued to be prescribed opioid pain medications or did not receive substance use disorder treatment.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Bill Text (committee substitute) — source
Votes
- 3/5 — 40–0 (pass) · lower
- SM — 18–0 (pass) · upper
Sponsors
- David Bentz — primary (person)
- Stephanie L. Hansen — primary (person)
- Bryan Townsend — cosponsor (person)
- David P. Sokola — cosponsor (person)
- Ernesto B Lopez — cosponsor (person)
- Gerald L. Brady — cosponsor (person)
- Gregory F. Lavelle — cosponsor (person)
- Helene M. Keeley — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Timothy D. Dukes — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2018-05-08 Introduced and Assigned to Health, Children & Social Services Committee in Senate
introduction, referral-committee - 2018-06-06 Reported Out of Committee (Health, Children & Social Services) in Senate with 5 On Its Merits
committee-passage - 2018-06-07 Passed By Senate. Votes: 18 YES 3 ABSENT
passage - 2018-06-12 Assigned to Health & Human Development Committee in House
introduction, referral-committee - 2018-06-13 Reported Out of Committee (Health & Human Development) in House with 10 On Its Merits
committee-passage - 2018-06-26 Passed By House. Votes: 40 YES 1 ABSENT
passage - 2018-09-10 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ae21e5c5-aaa4-466e-9ae0-817eb260cf17. Confidence: reported (aggregated from official Delaware legislature records).